[1-Naphthalen-1-yl-meth-(E)-ylidene]-hydrazine

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: [1-Naphthalen-1-yl-meth-(E)-ylidene]-hydrazine
• 英文别名: 1-Naphthaldehyde hydrazone；(E)-naphthalen-1-ylmethylidenehydrazine
• 化学式: C₁₁H₁₀N₂
• mdl: MFCD00174935
• 分子量: 170.214
• InChiKey: KOFMRKRCOBJBNR-MDWZMJQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38.4
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-萘甲醛 在 一水合肼 作用下， 以 异丙醇 为溶剂， 以48%的产率得到[1-Naphthalen-1-yl-meth-(E)-ylidene]-hydrazine
  参考文献：
  名称：

  Diarylsemicarbazones: synthesis, antineoplastic activity and topoisomerase I inhibition assay

  摘要：

  A series of diarylsemicarbazones was synthesized and tested against human neoplastic cell lines. The more active members have a 1-naphthyl ring at the carbamidic nitrogen, and chloro, dimethylamino or nitro group substituents at the benzylidene moiety. None of these showed affinity to DNA. One of the more active compounds was tested as a topoisomerase I inhibitor and showed a potent effect. SAR studies demonstrated linear correlation between lypophilicity and activity on the most sensitive lines and a definite conformational shape for antineoplastic action. (C) 1999 Elsevier Science S.A. All rights reserved.

  DOI：

  10.1016/s0014-827x(99)00050-6

文献信息

• [EN] PROCESS FOR THE SYNTHESIS OF BETA-AMINOCARBONYLS<br/>[FR] PROCÉDÉ DE SYNTHÈSE DE BÉTA-AMINOCARBONYLES
  申请人：UNIV OTTAWA

  公开号：WO2013067646A1

  公开（公告）日：2013-05-16

  The present application provides processes and intermediates useful in the production of β- aminocarbonyl- or β-aminothiocarbonyl-containing compounds. Provided herein is a process for synthesizing β-aminocarbonyl- or β-aminothiocarbonyl-containing compounds from an alkene and a hydrazone. Also provided herein is a process for synthesizing β-aminocarbonyl- or β-aminothiocarbonyl-containing compounds from an alkene and a hydrazine. The present application further provides intermediate aminoisocyanate and iminoisocyanate compounds, and methods for synthesizing the starting hydrazone and hydrazine compounds.

  本申请提供了在生产β-氨基羰基或β-氨基硫代羰基含有化合物中有用的过程和中间体。本文提供了一种从烯烃和肼酮合成β-氨基羰基或β-氨基硫代羰基含有化合物的方法。本文还提供了一种从烯烃和肼合成β-氨基羰基或β-氨基硫代羰基含有化合物的方法。本申请进一步提供了中间体氨基异氰酸酯和亚氨基异氰酸酯化合物，以及合成起始肼酮和肼化合物的方法。
• [EN] 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT<br/>[FR] DERIVES DE 7H-PYRROLO[2,3-D]PYRIMIDINE ET LEURS SELS ACCEPTABLES D'UN POINT DE VUE THERAPEUTIQUE, PREPARATIONS PHARMACEUTIQUES LES CONTENANT ET PROCEDE DE PRODUCTION DE L'AGENT ACTIF
  申请人：SZOLCSANYI JANOS

  公开号：WO2005105804A1

  公开（公告）日：2005-11-10

  The invention relates to new 7H-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for producing the active agent. The pharmaceutical preparation is adventageously antiphlogistic and analgetic one, a preparation reducing neuropathic hyperalgesia and rheumatic arthritis, a preparation for hindering destruction of bones chondrus, being applicable for treatment of other diseases, which may be connected with other inflammatory processes e.g. asthma, eczema or psoriasis.

  这项发明涉及新的7H-吡咯[2,3-d]嘧啶衍生物，以及它们的治疗可接受的盐、含有它们的药物制剂和生产活性剂的过程。药物制剂具有抗炎和镇痛的优势，可减少神经病性过敏和类风湿性关节炎，可用于阻止骨骨软骨的破坏的制剂，适用于治疗可能与其他炎症过程相关的其他疾病，例如哮喘、湿疹或牛皮癣。
• [EN] COMPOSITIONS AND METHODS FOR INHIBITING GROUP II INTRON RNA<br/>[FR] COMPOSITIONS ET MÉTHODES POUR INHIBER DES ARN D'INTRON DE GROUPE II
  申请人：UNIV YALE

  公开号：WO2019147894A1

  公开（公告）日：2019-08-01

  The present invention provides compositions and methods for inhibiting group II intron splicing for treating or preventing a disease or disorder associated with an organism harboring an active group II intron. The present invention also provides compositions and methods for inhibiting group II intron splicing for inhibiting, preventing or reducing growth of an organism harboring an active group II intron.

  本发明提供了用于抑制II类内含子剪接的组合物和方法，用于治疗或预防与携带活跃II类内含子的生物体相关的疾病或紊乱。本发明还提供了用于抑制II类内含子剪接，以抑制、预防或减少携带活跃II类内含子的生物体生长的组合物和方法。
• [EN] GLUCAGON ANTAGONISTS/INVERSE AGONISTS<br/>[FR] ANTAGONISTES/AGONISTES INVERSES DU GLUCAGON
  申请人：NOVO NORDISK AS

  公开号：WO1999001423A1

  公开（公告）日：1999-01-14

  Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof. The compounds act to antagonize the action of the glucagon peptide hormone.

  非肽化合物包含一个中心肼基结构，并且其合成方法。这些化合物作用是拮抗胰高血糖素肽激素的作用。
• 7H-Pyrrolo[2,3-D]Pyrimidine Derivatives, As Well As Their Therapeutically Acceptable Salts, Pharmaceutical Preparations Containing Them And Process For Production The Active Agent
  申请人：Szolcsanyi Janos

  公开号：US20080214583A1

  公开（公告）日：2008-09-04

  The invention relates to new 7H-pyrrolo[2,3-d]pyrimidine derivatives, as well as their therapeutically acceptable salts, pharmaceutical preparations containing them and process for producing the active agent. The pharmaceutical preparation is adventageously antiphlogistic and analgetic one, a preparation reducing neuropathic hyperalgesia and rheumatic arthritis, a preparation for hindering destruction of bones chondrus, being applicable for treatment of other diseases, which may be connected with other inflammatory processes e.g. asthma, eczema or psoriasis.

  本发明涉及新的7H-吡咯并[2,3-d]嘧啶衍生物及其治疗上可接受的盐、含有它们的制药制剂和活性剂的生产过程。该制药制剂具有抗炎和镇痛作用，可减轻神经病性疼痛和风湿性关节炎，防止软骨破坏，可用于治疗其他可能与其他炎症过程相关的疾病，例如哮喘、湿疹或牛皮癣。